• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性含硼凝血酶抑制剂——X射线分析揭示出惊人的结合模式。

Selective boron-containing thrombin inhibitors--X-ray analysis reveals surprising binding mode.

作者信息

von Matt A, Ehrhardt C, Burkhard P, Metternich R, Walkinshaw M, Tapparelli C

机构信息

Novartis Pharma AG, Basel, Switzerland.

出版信息

Bioorg Med Chem. 2000 Sep;8(9):2291-303. doi: 10.1016/s0968-0896(00)00147-4.

DOI:10.1016/s0968-0896(00)00147-4
PMID:11026541
Abstract

Based on the structural comparison of the S1 pocket in different trypsin-like serine proteases, a series of Boc-D-trimethylsilylalanine-proline-boro-X pinanediol derivatives, with boro-X being different amino boronic acids, have been synthesized as inhibitors of thrombin. Among the novel compounds, a number of derivatives were synthesized which appeared to have side-chain variants too big to fit into the S1 pocket. Nevertheless, these compounds inhibited thrombin in the nM range. The X-ray structure of one of these inhibitors bound to the active side of thrombin reveals that a new binding mode is responsible for these surprising results.

摘要

基于对不同胰蛋白酶样丝氨酸蛋白酶中S1口袋的结构比较,已合成了一系列Boc-D-三甲基硅烷基丙氨酸-脯氨酸-硼-X蒎烷二醇衍生物(其中硼-X为不同的氨基硼酸)作为凝血酶抑制剂。在这些新化合物中,合成了许多衍生物,其侧链变体似乎太大而无法装入S1口袋。然而,这些化合物在纳摩尔范围内抑制凝血酶。其中一种抑制剂与凝血酶活性位点结合的X射线结构表明,一种新的结合模式导致了这些惊人的结果。

相似文献

1
Selective boron-containing thrombin inhibitors--X-ray analysis reveals surprising binding mode.选择性含硼凝血酶抑制剂——X射线分析揭示出惊人的结合模式。
Bioorg Med Chem. 2000 Sep;8(9):2291-303. doi: 10.1016/s0968-0896(00)00147-4.
2
Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.选择性含硼凝血酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem. 1999 Jul;7(7):1295-307. doi: 10.1016/s0968-0896(99)00069-3.
3
Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.采用基于配体和基于结构的联合方法,剖析代表性因子 Xa 和凝血酶抑制剂的选择性结构决定因素。
J Chem Inf Model. 2011 Aug 22;51(8):1966-85. doi: 10.1021/ci200185q. Epub 2011 Aug 1.
4
In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.基于三肽的α-酮杂环作为凝血酶抑制剂的深入研究。S1'亚位点的有效利用及其对基于结构的药物设计的意义。
J Med Chem. 2005 Mar 24;48(6):1984-2008. doi: 10.1021/jm0303857.
5
Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.选择S18326作为一种新型强效且选择性的硼酸直接凝血酶抑制剂。
Thromb Haemost. 1997 Oct;78(4):1221-7.
6
Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity.基于结构设计强效的、脒基衍生的凝血因子Xa抑制剂:选择性、抗凝活性和抗血栓形成活性的评估
J Med Chem. 2000 Mar 9;43(5):883-99. doi: 10.1021/jm9903287.
7
Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.新型非共价凝血酶抑制剂,其包含P(1) 4,5,6,7-四氢苯并噻唑精氨酸侧链模拟物。
Eur J Med Chem. 2004 Mar;39(3):257-65. doi: 10.1016/j.ejmech.2003.12.006.
8
New inhibitors of thrombin and other trypsin-like proteases: hydrogen bonding of an aromatic cyano group with a backbone amide of the P1 binding site replaces binding of a basic side chain.凝血酶及其他类胰蛋白酶的新型抑制剂:芳香族氰基与P1结合位点主链酰胺之间的氢键作用取代了碱性侧链的结合。
Biochemistry. 1997 Oct 28;36(43):13180-6. doi: 10.1021/bi970912m.
9
Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site.
J Med Chem. 1997 Mar 14;40(6):830-2. doi: 10.1021/jm960762y.
10
Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.精制的2.3A 牛凝血酶与基于苯甲脒和精氨酸的凝血酶抑制剂NAPAP、4-TAPAP和MQPA形成的X射线晶体结构。改进抗血栓药物的起点。
J Mol Biol. 1992 Aug 20;226(4):1085-99. doi: 10.1016/0022-2836(92)91054-s.